These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28749644)

  • 41. The clinical and economic benefits of school-based quadrivalent HPV vaccination in Singapore.
    Tay SK; Hsu TY; Shcheprov A; Walia A; Kulkarni AS
    Int J Gynaecol Obstet; 2017 May; 137(2):129-137. PubMed ID: 28190260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Model for assessing human papillomavirus vaccination strategies.
    Elbasha EH; Dasbach EJ; Insinga RP
    Emerg Infect Dis; 2007 Jan; 13(1):28-41. PubMed ID: 17370513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: a transmission dynamic model-based evaluation.
    Insinga RP; Dasbach EJ; Elbasha EH; Puig A; Reynales-Shigematsu LM
    Vaccine; 2007 Dec; 26(1):128-39. PubMed ID: 18055075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study.
    Kiendrébéogo JA; Sidibe ARO; Compaoré GB; Nacanabo R; Sory O; Ouédraogo I; Nawaz S; Schuind AE; Clark A
    BMC Health Serv Res; 2023 Dec; 23(1):1338. PubMed ID: 38041075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.
    Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
    Vaccine; 2013 Aug; 31(37):3899-905. PubMed ID: 23820080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.
    Guerrero AM; Genuino AJ; Santillan M; Praditsitthikorn N; Chantarastapornchit V; Teerawattananon Y; Alejandria M; Toral JA
    BMC Public Health; 2015 Jul; 15():730. PubMed ID: 26223975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana.
    Vodicka E; Nonvignon J; Antwi-Agyei KO; Bawa J; Clark A; Pecenka C; LaMontagne DS
    Vaccine; 2022 Mar; 40 Suppl 1():A85-A93. PubMed ID: 34303563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of HPV vaccination in Belize.
    Walwyn L; Janusz CB; Clark AD; Prieto E; Waight E; Largaespada N
    Vaccine; 2015 May; 33 Suppl 1():A174-81. PubMed ID: 25919158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia.
    Uusküla A; Müürsepp A; Kawai K; Raag M; Jürisson M; Pillsbury M
    BMC Infect Dis; 2013 Jul; 13():304. PubMed ID: 23819789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The cost-effectiveness of male HPV vaccination in the United States.
    Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
    Vaccine; 2011 Oct; 29(46):8443-50. PubMed ID: 21816193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of the introduction of two-dose bi-valent (Cervarix) and quadrivalent (Gardasil) HPV vaccination for adolescent girls in Bangladesh.
    Mahumud RA; Gow J; Alam K; Keramat SA; Hossain MG; Sultana M; Sarker AR; Islam SMS
    Vaccine; 2020 Jan; 38(2):165-172. PubMed ID: 31668820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Clinical and Economic Impact of a Nonavalent Versus Bivalent Human Papillomavirus National Vaccination Program in Taiwan.
    Chou HH; Chang SC; Sukarom I; Saxena K; Pavelyev A; Wu YH; Chang CJ
    Value Health Reg Issues; 2022 Nov; 32():79-87. PubMed ID: 36116338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.
    Marty R; Roze S; Bresse X; Largeron N; Smith-Palmer J
    BMC Cancer; 2013 Jan; 13():10. PubMed ID: 23298365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-Utility Analysis of Human Papillomavirus Vaccination and Cervical Screening on Cervical Cancer Patient in Indonesia.
    Setiawan D; Dolk FC; Suwantika AA; Westra TA; WIlschut JC; Postma MJ
    Value Health Reg Issues; 2016 May; 9():84-92. PubMed ID: 27881267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program.
    Pearson AL; Kvizhinadze G; Wilson N; Smith M; Canfell K; Blakely T
    BMC Infect Dis; 2014 Jun; 14():351. PubMed ID: 24965837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France.
    Bergeron C; Largeron N; McAllister R; Mathevet P; Remy V
    Int J Technol Assess Health Care; 2008; 24(1):10-9. PubMed ID: 18218164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Revisiting the cost-effectiveness of universal HPV-vaccination in Denmark accounting for all potentially vaccine preventable HPV-related diseases in males and females.
    Olsen J; Jørgensen TR
    Cost Eff Resour Alloc; 2015; 13():4. PubMed ID: 25694771
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.